DIS vs STRO
Walt Disney Company (DIS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Bob Iger.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DIS currently screens at market cap $175.14B and trailing P/E 16.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DIS and STRO stock pages for the full models.
Not investment advice.